MetaVia Inc. (MTVA) stock
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06−0.19 (-15.20%)
Close on Nov 18, 2026Market cap $6.98MP/E –Yield –
MetaVia free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
MetaVia's free cash flow for the twelve months ending Dec 31, 2025 was -$15.70M. For fiscal 2025 it was -$15.70M. The highest annual figure on record is -$7.25M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.70M | – |
| FY2024 | Dec 31, 2024 | -$24.72M | – |
| FY2023 | Dec 31, 2023 | -$10.85M | – |
| FY2021 | Dec 31, 2021 | -$15.14M | – |
| FY2020 | Dec 31, 2020 | -$10.77M | – |
| FY2019 | Dec 31, 2019 | -$7.25M | – |
| FY2018 | Dec 31, 2018 | -$14.45M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$4.86M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.96M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.47M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.55M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.25M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.40M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.85M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.05M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.55M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.51M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.35M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.95M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.32M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.14M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.37M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.44M | – |
See a number that looks wrong?